Does executive functioning contribute to locomotion in amyotrophic lateral sclerosis patients?

Area of Science:

• Neurology
• Neuroscience
• Clinical Medicine

Background:

• Amyotrophic lateral sclerosis (ALS) frequently presents with both motor and cognitive deficits.
• The interplay between cognitive and motor impairments in ALS remains underexplored.
• Executive functioning is a key cognitive domain potentially impacting motor performance.

Purpose of the Study:

• To investigate the relationship between executive functioning and mobility in ambulant patients with amyotrophic lateral sclerosis.
• To test the hypothesis that impaired executive functioning is associated with reduced mobility in ALS patients.

Main Methods:

• A cohort of 49 non-demented, ambulant ALS patients underwent assessment.
• Executive function was evaluated using the Frontal Assessment Battery (FAB).
• Locomotion was measured via the Timed Up and Go (TUG) and its imagined version (iTUG) bedside tests.

Main Results:

• No significant correlation was observed between FAB scores and TUG or iTUG results.
• Executive function, assessed by the FAB and its subtests, did not correlate with overall disability (ALSFRS-R).
• The study found no link between cognitive screening measures and motor performance in this ALS cohort.

Conclusions:

• Executive function and locomotion are not significantly correlated in non-demented, ambulant ALS patients using standard screening tools.
• Mobility in ALS patients may be primarily influenced by non-cognitive factors, including muscle weakness and pyramidal signs.
• Further research is needed to elucidate the complex relationship between cognitive and motor symptoms in ALS.